| Entry |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Cefoxitin sodium (JAN/USP); Mefoxin (TN) | ||||||||||
| Product | CEFOXITIN AND DEXTROSE (B. Braun Medical) | ||||||||||
| Generic | CEFOXITIN (Hikma Pharmaceuticals USA), CEFOXITIN (SAMSON MEDICAL TECHNOLOGIES LLC), CEFOXITIN (Sagent Pharmaceuticals), CEFOXITIN (Sagent Pharmaceuticals), CEFOXITIN (WG Critical Care), CEFOXITIN (WG Critical Care), CEFOXITIN (WG Critical Care), CEFOXITIN (West-Ward Pharmaceuticals Corp), CEFOXITIN (Fresenius Kabi USA), CEFOXITIN (Fresenius Kabi USA) | ||||||||||
| Formula | C16H16N3O7S2. Na | ||||||||||
| Exact mass | 449.0327 | ||||||||||
| Mol weight | 449.4339 | ||||||||||
| Structure |  | ||||||||||
| Simcomp | |||||||||||
| Class | Antibacterial DG01710 beta-Lactam antibiotic DG01714 Cephalosporin skeleton group DG01488 Cephem DG01775 Second-generation cephalosporin | ||||||||||
| Remark |
| ||||||||||
| Efficacy | Antibacterial, Cell wall biosynthesis inhibitor | ||||||||||
| Target | penicillin binding protein | ||||||||||
| Pathway |
| ||||||||||
| Interaction | |||||||||||
| Structure map |
| ||||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] J ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE J01D OTHER BETA-LACTAM ANTIBACTERIALS J01DC Second-generation cephalosporins J01DC01 Cefoxitin D00913 Cefoxitin sodium (JAN/USP) <US> USP drug classification [BR:br08302] Antibacterials Beta-lactam, Cephalosporins Cefoxitin D00913 Cefoxitin sodium (JAN/USP) Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01714 Cephalosporin skeleton group DG01488 Cephem DG00557 Cefoxitin D00913 Cefoxitin sodium DG01775 Second-generation cephalosporin DG00557 Cefoxitin D00913 Cefoxitin sodium Drug classes [BR:br08332] Antibacterial DG01488 Cephem D00913 Cefoxitin sodium Antimicrobials [BR:br08307] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam Second-generation cephalosporin D00913 Cefoxitin sodium (JAN/USP) <US> Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01714 Cephalosporin skeleton group DG01488 Cephem DG00557 Cefoxitin DG01775 Second-generation cephalosporin DG00557 Cefoxitin Antimicrobials abbreviations [BR:br08327] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam Second-generation cephalosporin DG00557 Cefoxitin | ||||||||||
| Other DBs |
| ||||||||||
| KCF data | ATOM 29 1 C1y C 27.7461 -15.3839 2 N1y N 27.7461 -16.7490 3 C2y C 28.9283 -17.4313 4 C2y C 30.1104 -16.7490 5 C1x C 30.1104 -15.3839 6 S2x S 28.9283 -14.7015 7 C1z C 26.3810 -15.3839 8 C5x C 26.3810 -16.7490 9 N1b N 25.1991 -14.7015 10 C5a C 24.0170 -15.3839 11 O5a O 24.0170 -16.7490 12 O5x O 25.1991 -17.4313 13 C1b C 22.8349 -14.7015 14 C1b C 31.3106 -17.4423 15 C6a C 28.9283 -18.7961 16 O6a O 27.7297 -19.4882 17 O6a O 30.0937 -19.4691 #- 18 O2a O 26.3810 -13.1996 19 C1a C 27.5606 -12.5184 20 O7a O 32.4982 -16.7572 21 C7a C 33.6989 -17.4511 22 N1a N 34.8805 -16.7695 23 O6a O 33.6986 -18.8617 24 C8y C 21.6426 -15.3894 25 S2x S 20.5184 -14.5554 26 C8x C 19.3798 -15.3651 27 C8x C 19.7979 -16.6982 28 C8x C 21.1950 -16.7125 29 Z Na 31.5700 -19.4600 #+ BOND 30 1 1 2 1 2 2 3 1 3 3 4 2 4 4 5 1 5 5 6 1 6 1 6 1 7 1 7 1 8 7 8 1 9 2 8 1 10 7 9 1 #Up 11 9 10 1 12 10 11 2 13 8 12 2 14 10 13 1 15 4 14 1 16 3 15 1 17 15 16 2 18 15 17 1 19 7 18 1 #Down 20 18 19 1 21 14 20 1 22 20 21 1 23 21 22 1 24 21 23 2 25 13 24 1 26 24 25 1 27 25 26 1 28 26 27 2 29 27 28 1 30 24 28 2 |